IMO those that sold (hurriedly) based on the Bernstein report sold on Thursday... when the report was released in the am. it was a rolling snowball that has now melted.
Back to the fundamentals... Sandoz M-enox is selling aross the US. This is huge for a company like MNTA w/ only 45M shares.
one does not have to be a math wiz to see what $1B+/year in sales of a high margin product will do for a small cap company like MNTA and a lot (if not all) of the Teva risk has now been washed out.
Keep in mind MNTA is about more than M-enox.
The creation of a thousand forests is in one acorn.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.